New guidelines regarding medications for gastrointestinal bleeding were jointly released by the American College of Gastroenterology and the Canadian Association of Gastroenterology on March 21. This ...

Gastrointestinal (GI) bleeding is a symptom of a disease, condition, or injury affecting any part of the gastrointestinal tract. The GI tract includes the esophagus, stomach, small intestine, colon ...

Please provide your email address to receive an email when new articles are posted on . Data suggest that apixaban, a direct oral anticoagulant, may be preferable to other drugs in its category as it ...

In the study of over 200 patients, 90.1% of those who received TC-325 had their bleeding controlled within 30 days, as compared to 81.4% of those who received standard treatment, meeting criteria for ...

Every year in the U.S., doctors perform more than 1 million endoscopic hemostasis procedures to treat gastrointestinal bleeding, the majority of which are upper GI bleeds. One popular treatment method ...

Treatment with thalidomide led to a reduction in bleeding among patients with recurrent bleeding due to small-intestinal angiodysplasia (SIA), a randomized trial showed. In 150 patients, 68.6% of ...

Gastrointestinal bleeding is common among people with cirrhosis due to a complication called portal hypertension. This is elevated blood pressure in the veins that lead to your liver. Cirrhosis is ...

Please provide your email address to receive an email when new articles are posted on . Rivaroxaban appeared associated with a higher rate of gastrointestinal bleeding than other direct oral ...

Antidepressants called selective serotonin reuptake inhibitors, or SSRIs, are a mainstay of depression treatment, but a new study warns that taking common painkillers alongside SSRIs may raise the ...

ATLANTA, Georgia — Patients with atrial fibrillation receiving anticoagulant therapy are more likely to experience gastrointestinal (GI) bleeding when treated with rivaroxaban than when treated with ...

Bleeding from the lower gastrointestinal (GI) tract shouldn't be seen as simply a manageable adverse effect of oral anticoagulation (OAC) for atrial fibrillation (AF). Rather, it's a red flag that the ...